Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies
Data up to Jan 2025
Total Citations Per Year
Abstract
References (21)
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
1992 • 483 citations
NMR and Molecular Modeling Investigation of the Mechanism of Activation of the Antitumor Drug Temozolomide and Its Interaction with DNA
1994 • 417 citations
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.
1987 • 386 citations
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.
1995 • 290 citations
Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours
1993 • 276 citations
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
1997 • 221 citations
The charing cross hospital experience with temozolomide in patients with gliomas
1996 • 157 citations
Activity of temozolomide in the treatment of central nervous system tumor xenografts.
1995 • 145 citations
In vitro evaluation of temozolomide combined with X-irradiation
1997 • 144 citations
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.
1994 • 131 citations
3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity
1996 • 121 citations
Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer.
1997 • 94 citations
In vitro and in vivo methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistant to chloroethylnitrosoureas.
1987 • 75 citations
Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot study
1996 • 74 citations
Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity
1990 • 65 citations
Effect of single and multiple administration of an O ? 6 -benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model
1997 • 59 citations
Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction
1995 • 55 citations
Chemosensitivity to triazene compounds and O6-alkylguanine-DNA alkyltransferase levels: Studies with blasts of leukaemic patients
1995 • 53 citations
High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma
1997 • 44 citations
Neck Dissection: Past, Present, Future
2005 • 42 citations
High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma
1997 • 13 citations